Recently, Hainan Leyun Biotechnology Co., Ltd. (海南乐孕生物科技有限公司) received CNY tens of millions in Series B financing, and the investor is the Swiss global financial group Cedrus Investment.
DACHAO (达巢) is a brand of Hainan Leyun, which focuses on providing customized products for women's reproductive health. Whether it is menarche or menopause, DACHAO provides solutions for health care, restoration, and enhancement of reproductive health for women of different ages and life stages. These solutions are matched, professionally, and scientifically designed to meet the specific needs of Asian women, providing them with unique product choices.
The research and development results of DACHAO come from a team composed of returned doctors from Stanford University in the United States, who have been committed to academic research for a long time. With the support of horizontal projects carried out by Hainan Leyun, the State Key Laboratory, and the clinical observation of experts from a number of tertiary hospitals, after 5 years of continuous research and development, Hainan Leyun has successfully launched a series of reproductive nutrition such as DACHAO Reco18, Reju28, and PCOS.
According to Mordor Intelligence, in 2019, the total value of the European nutritional supplement market reached EUR 13.2 billion, of which Italy occupied the main market position with a market share of 27% (2019 Italian nutritional supplement market was valued at EUR 3.56 billion, an increase of 4.3% compared to 2018 sales). In the field of medical practice, a total of 28.6 million prescriptions for nutritional supplements were issued in 2019, of which prescription supplements in the field of gynecology accounted for 14%.
At present, many products of DACHAO have passed the authoritative certification of the US Food Administration (FDA), food safety certification (HACCP), good manufacturing practice certification (GMP), and international consumer quality certification (ISO).
Healthcare products have attracted a lot of companies. Representative companies in China include Joincare (健康元), BY-HEALTH (汤臣倍健), Beingmate (贝因美), and JUNLEBAO (君乐宝); internationally, Amway, GNC, and Natures Bounty in the United States, Doppelherz in Germany, Jamieson in Canada, and ESI in Italy are quite powerful.
Hainan Leyun's this round of funds is mainly used for the innovative research and development of reproductive health and anti-aging products, as well as to promote the internationalization of products, and promote domestic nutrition brands to gain a foothold in China and go global.